Agencies

NSF advances 29 semifinalists in the second NSF Regional Innovation Engines competition

Published: 8 July 2025
Categories: National Science Foundation

RSS feed source: National Science Foundation

The U.S. National Science Foundation Regional Innovation Engines (NSF Engines) program announced the 29 semifinalists advancing to the next stage of the second competition – spanning critical technologies and applications ranging from energy grid security to maximizing the yield of critical minerals mining to advanced optical sensors. The semifinalist teams, many of whom have been building their regional coalitions for a year or longer, are led by universities, nonprofits, private industry and other organizations from across the United States. View a map of the NSF Engines semifinalists.

Credit: U.S. National Science Foundation

A map showing the locations of the U.S. National Science Foundation Regional Innovation Engines (NSF Engines) program’s 29 finalists for 2025. Explore the map semifinalists in more detail.

“This outstanding cohort of semifinalists clearly demonstrates that America’s technology competitiveness will depend as much on expanding our ability to unlock innovation capacity in every part of our country — from the rural plains and western ranges to cities with rich industrial and manufacturing legacies — as it will on advancing the technologies themselves,” said Erwin Gianchandani, NSF assistant director for Technology, Innovation and Partnerships (NSF TIP). “Each team was selected because it brought strong public and private partners to the table and outlined a promising vision for research, innovation and workforce development in

Click this link to continue reading the article on the source website.

Breast Cancer Risk in Younger Women May Be Influenced by Hormone Therapy

Published: 30 June 2025
Categories: National Institute of Environmental Health Sciences

RSS feed source: National Science Foundation

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. Researchers discovered that women treated with unopposed estrogen hormone therapy (E-HT) were less likely to develop the disease than those who did not use hormone therapy. They also found that women treated with estrogen plus progestin hormone therapy (EP-HT) were more likely to develop breast cancer than women who did not use hormone therapy. Together, these results could help to guide clinical recommendations for hormone therapy use among younger women.

Click this link to continue reading the article on the source website.